YOUR SEARCH FOR Text 194 RESULTS
141 of Total
Global Biopharmaceutical Company | Incyte.com
… Incyte is a Biopharmaceutical Company on a Mission to …
142 of Total
Financials | Incyte
… Annual Reports Quarterly Reports SEC Filings The information contained in prior press releases, reports, …
143 of Total
0000879169-22-000010 | 10-Q | Incyte
… Annual Reports Quarterly Reports SEC Filings SEC Filing … 2022 Document Date Sep 30, 2022 Form Description Quarterly report which provides a continuing …
144 of Total
0000879169-23-000016 | 10-Q | Incyte
… Annual Reports Quarterly Reports SEC Filings SEC Filing … 2023 Document Date Mar 31, 2023 Form Description Quarterly report which provides a continuing …
145 of Total
0000879169-23-000025 | 10-Q | Incyte
… Annual Reports Quarterly Reports SEC Filings SEC Filing … 2023 Document Date Jun 30, 2023 Form Description Quarterly report which provides a continuing …
146 of Total
0000879169-23-000041 | 10-Q | Incyte
… Annual Reports Quarterly Reports SEC Filings SEC Filing … 2023 Document Date Sep 30, 2023 Form Description Quarterly report which provides a continuing …
147 of Total
0000879169-24-000077 | 10-Q | Incyte
… Annual Reports Quarterly Reports SEC Filings SEC Filing … 2024 Document Date Mar 31, 2024 Form Description Quarterly report which provides a continuing …
148 of Total
0000879169-24-000149 | 10-Q | Incyte
… Annual Reports Quarterly Reports SEC Filings SEC Filing … 2024 Document Date Jun 30, 2024 Form Description Quarterly report which provides a continuing …
149 of Total
0000879169-24-000172 | 10-Q | Incyte
… Annual Reports Quarterly Reports SEC Filings SEC Filing … 2024 Document Date Sep 30, 2024 Form Description Quarterly report which provides a continuing …
150 of Total
0000879169-25-000056 | 10-Q | Incyte
… Annual Reports Quarterly Reports SEC Filings SEC Filing … 2025 Document Date Mar 31, 2025 Form Description Quarterly report which provides a continuing …